Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 20.95
+0.05 (0.24%)
At close: Jul 9, 2026
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 6.5 billion as of July 9, 2026. Its market cap has increased by 1.94% in one year.
Market Cap
6.50B
Enterprise Value
5.06B
Revenue
1.17B
Ranking
n/a
PE Ratio
27.06
Stock Price
20.95
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 6.50B, an increase of 73.42%. That is a compound annual growth rate of 4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.50B | 13.86% |
| Dec 31, 2025 | 5.71B | -11.78% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acepodia | 7.69B |
| Adimmune | 7.44B |
| TaiGen Biopharmaceuticals Holdings | 6.48B |
| Sinphar Pharmaceutical | 6.33B |
| AnnJi Pharmaceutical | 6.10B |
| TWi Biotechnology | 5.59B |
| Mycenax Biotech | 5.39B |
| Medigen Biotechnology | 5.24B |